Thus, in the light of all these evidences suggesting that STAT3 and STAT5A play critical roles in cancer progression, the present study investigated the nature and extent of the involvement of STAT3 and STAT5A in the therapeutic response and disease progression of patients with GBM. Here, STAT5A is linked to glioblastoma.